Home Care Improvement Intervention for Heart Failure
(I-TRANSFER-HF Trial)
Trial Summary
What is the purpose of this trial?
This study is trying to improve the hospital-to-home transition for people with heart failure who receive home care services. The study will test an intervention called I-TRANSFER-HF, which differs from usual care by combining early home health nurse visits and outpatient medical appointments. The study is interested in two questions: 1. Is I-TRANSFER-HF better than usual care at preventing heart failure patients from returning to the hospital within 30 days? 2. Are there parts of I-TRANSFER-HF that are easy or hard to implement in the real world? The researchers will answer these questions by testing the intervention among pairs of hospitals and home health agencies across the country. During the study, the hospital-agency pairs will be asked to implement I-TRANSFER-HF. The researchers will then compare the results from before and after I-TRANSFER-HF was adopted. They will also interview people from these hospitals and agencies to see how I-TRANSFER-HF is being implemented under real-world conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on improving care transitions rather than changing medication regimens.
What data supports the effectiveness of the treatment I-TRANSFER-HF for heart failure patients?
Research shows that home health interventions, like CareNavRN, can improve heart failure patients' knowledge, self-care, and quality of life, and may reduce hospital readmissions. Although the results were not statistically significant, they suggest that such interventions could be beneficial during the transition from hospital to home.12345
Is the Home Care Improvement Intervention for Heart Failure safe for humans?
What makes the I-TRANSFER-HF treatment unique for heart failure patients?
The I-TRANSFER-HF treatment is unique because it focuses on improving the transition from hospital to home for heart failure patients by using specially trained home health nurses who visit patients weekly for four weeks. This approach aims to reduce hospital readmissions and improve patients' knowledge, self-care, and quality of life, which is different from standard treatments that may not provide such personalized, ongoing support at home.236910
Research Team
Madeline R Sterling, MD, MPH, MS
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for adults hospitalized with heart failure transitioning from certain hospitals to home health care (HHC) services. It includes healthcare professionals involved in this transition process at participating hospital-HHC pairs. Excluded are patients discharged elsewhere, on dialysis, or with left ventricular devices.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of I-TRANSFER-HF, combining early home health nurse visits and outpatient medical appointments
Follow-up
Participants are monitored for safety and effectiveness after intervention
Treatment Details
Interventions
- I-TRANSFER-HF
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Johns Hopkins University
Collaborator
University of Colorado, Denver
Collaborator
NYU Langone Health
Collaborator
University of California, San Diego
Collaborator